Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological:
Behavioural genetics ·
Evolutionary psychology ·
Neuroanatomy ·
Neurochemistry ·
Neuroendocrinology ·
Neuroscience ·
Psychoneuroimmunology ·
Physiological Psychology ·
Psychopharmacology
(Index , Outline )
2,5-Dimethoxy-4-methylamphetamine
2,5-Dimethoxy-4-methylamphetamine
General
Systematic name
?
Other names
?
Molecular formula
?
SMILES
?
Molar mass
?.?? g/mol
Appearance
?
CAS number
[?-?-?]
Properties
Density and phase
? g/cm³, ?
Solubility in water
? g/100 ml (?°C)
Melting point
?°C (? K)
Boiling point
?°C (? K)
Acidity (pK a )
?
Basicity (pK b )
?
Chiral rotation [α]D
?°
Viscosity
? cP at ?°C
Structure
Molecular shape
?
Coordination geometry
?
Crystal structure
?
Dipole moment
? D
Hazards
MSDS
External MSDS
Main hazards
?
NFPA 704
Flash point
?°C
R/S statement
R : ? S : ?
RTECS number
?
Supplementary data page
Structure and properties
n , εr , etc.
Thermodynamic data
Phase behaviour Solid, liquid, gas
Spectral data
UV , IR , NMR , MS
Related compounds
Other anions
?
Other cations
?
Related ?
?
Related compounds
?
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references
2,5-Dimethoxy-4-methylamphetamine (DOM ; known on the street as STP , standing for "Serenity, Tranquility, and Peace ") is a psychedelic and a substituted amphetamine . It was first synthesized by Alexander Shulgin , and later reported in his book PiHKAL: A Chemical Love Story . DOM is classified as a Schedule I substance in the United States, and is similarly controlled in other parts of the world. Internationally, it is a Schedule I drug under the Convention on Psychotropic Substances .[1] It is generally taken orally.
History [ ]
In mid-1967, tablets containing 20 mg (later 10 mg) of DOM were widely distributed in the Haight-Ashbury District of San Francisco under the name of STP. This short-lived appearance of DOM on the black market proved disastrous for several reasons. First, the tablets contained an excessively high dose of the chemical. This, combined with DOM’s slow onset of action (which encouraged some users, familiar with drugs that have quicker onsets, such as LSD , to re-dose) and its remarkably long duration, caused many users to panic and sent some to the emergency room. Second, treatment of such overdoses was complicated by the fact that no one at the time knew that the tablets called STP were, in fact, DOM.
Effects [ ]
Effects of this drug include substantial perceptual changes such as blurred vision, multiple images, vibration of objects, visual hallucinations, distorted shapes, enhancement of details, slowed passage of time, increased sexual drive and pleasure, and increased contrasts. It may also cause pupillary dilation and a rise in systolic blood pressure.[2]
Pharmacology [ ]
DOM is a selective 5-HT2A , 5-HT2B , and 5-HT2C receptor partial agonist . Its psychedelic effects are mediated by its agonistic properties at the 5-HT2A receptor. Due to its selectivity, DOM is often used in scientific research when studying the 5-HT2 receptor subfamily. DOM is a chiral molecule, and R -(-)-DOM is the more active enantiomer , functioning as a potent agonist of the serotonin 5-HT family of receptors; mainly of the 5-HT2 subtype.[3]
Analogues and derivatives [ ]
The 2,6-dimethoxy positional isomer of DOM, known as Ψ-DOM , is also mentioned in PiHKAL as being active, as is the alpha-ethyl homologue Ariadne . Analogues where the methoxy groups at the 2,5- positions of the aromatic ring have been altered have also been synthesised and tested as part of an effort to identify the binding mode of DOM at the 5-HT2A receptor. Both the 2- and 5- O-desmethyl derivatives 2-DM-DOM and 5-DM-DOM, and the 2- and 5- ethyl analogues 2-Et-DOM and 5-Et-DOM have been tested, but in all cases were significantly less potent than the corresponding methoxy compound, showing the importance of the oxygen lone pairs in 5-HT2A binding.[4] [5]
File:DOM-25-varients.png Template:Clear-left
Toxicity [ ]
Very little is known about the toxicity of DOM. According to Shulgin, the effects of DOM typically last 14 to 20 hours, though other clinical trials indicate a duration of 7 to 8 hours.[2]
Legal status [ ]
Canada [ ]
Listed as a Schedule 1 as it is an analogue of amphetamine.
United States [ ]
DOM is Schedule I in the United States. This means it is illegal to manufacture, buy, possess, or distribute (sell, trade or give) without a DEA license.
See also [ ]
2,5-Dimethoxy-4-Substituted Amphetamines
References [ ]
↑ Green List: List of Psychotropic Substances Under International Control . (PDF ) International Narcotics Control Board . URL accessed on 28 February 2012 .
↑ 2.0 2.1 Snyder, Solomon H., Louis Faillace and Leo Hollister (November 1967). 2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug. Science 158 (3801): 669–670.
↑ Sanders-Bush, E, Burris, KD; Knoth, K (September 1988). Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. The Journal of Pharmacology and Experimental Therapeutics 246 (3): 924–928.
↑ Eckler JR, Chang-Fong J, Rabin RA, Smith C, Teitler M, Glennon RA, Winter JC (July 2003). Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM. Pharmacology, Biochemistry, and Behavior 75 (4): 845–52.
↑ Template:Cite thesis
External links [ ]
[edit ] Psychedelic tryptamines
α,N,N-TMT ,
2,N,N-TMT ,
5,N,N-TMT ,
4-Acetoxy-DMT
4-Acetoxy-DET ,
4-Acetoxy-DIPT ,
4-HO-5-MeO-DMT ,
α-ET ,
α-MT ,
Baeocystin ,
Bufotenin ,
DET ,
DIPT ,
DMT ,
DPT ,
EIPT ,
Ethocin ,
Ethocybin ,
Miprocin ,
Iprocin ,
MET ,
MIPT ,
5-Me-MIPT
5-MeO-α-ET ,
5-MeO-α-MT ,
5-MeO-DALT ,
5-MeO-DET ,
5-MeO-DIPT ,
5-MeO-DMT ,
5-MeO-DPT ,
5-MeO-MIPT ,
5-MeO-2,N,N-TMT ,
Norbaeocystin ,
Psilocin ,
Psilocybin
Psychedelic lysergamides
AL-LAD •
ALD-52 •
BU-LAD •
CYP-LAD •
Diallyllysergamide •
DAM-57 •
Ergonovine •
ETH-LAD •
LAE-32 •
LSD •
LPD-824 •
LSM-775 •
D-Lysergic acid N-(α-hydroxyethyl)amide •
Methylergonovine •
MLD-41 •
PARGY-LAD •
PRO-LAD
Psychedelic mushrooms
List of Psilocybin mushrooms
Amanita muscaria •
Amanita pantherina •
Conocybe cyanopus •
Conocybe smithii •
Gymnopilus aeruginosus •
Gymnopilus luteofolius •
Gymnopilus purpuratus •
Gymnopilus spectabilis •
Inocybe aeruginascens •
Inocybe corydalina var. corydalina •
Inocybe tricolor •
Panaeolus subbalteatus •
Panaeolus tropicalis •
Pluteus salicinus •
Psilocybe •
Psilocybe atlantis •
Psilocybe aucklandii •
Psilocybe australiana •
Psilocybe azurescens •
Psilocybe baeocystis •
Psilocybe bohemica •
Psilocybe caerulipes •
Psilocybe cubensis •
Psilocybe cyanescens •
Psilocybe mexicana •
Psilocybe ovoideocystidiata •
Psilocybe semilanceata •
Psilocybe subaeruginascens •
Psilocybe subaeruginosa •
Psilocybe tampanensis •
Psilocybe villarrealiae •
Psilocybe weilii •
Psilocybe zapotecorum
.
Serotonergics
5-HT1 receptor ligands
Agonists : Azapirones : Alnespirone • Binospirone • Buspirone • Enilospirone • Eptapirone • Gepirone • Ipsapirone • Perospirone • Revospirone • Tandospirone • Tiospirone • Umespirone • Zalospirone ; Antidepressants : Etoperidone • Nefazodone • Trazodone ; Antipsychotics : Aripiprazole • Asenapine • Clozapine • Quetiapine • Ziprasidone ; Ergolines : Dihydroergotamine • Ergotamine • Lisuride • Methysergide • LSD ; Tryptamines : 5-CT • 5-MeO-DMT • 5-MT • Bufotenin • DMT • Indorenate • Psilocin • Psilocybin ; Others : 8-OH-DPAT • Adatanserin • Befiradol • BMY-14802 • Cannabidiol • Dimemebfe • Ebalzotan • Eltoprazine • F-11,461 • F-12,826 • F-13,714 • F-14,679 • F-15,063 • F-15,599 • Flesinoxan • Flibanserin • Lesopitron • Lu AA21004 • LY-293,284 • LY-301,317 • MKC-242 • NBUMP • Osemozotan • Oxaflozane • Pardoprunox • Piclozotan • Rauwolscine • Repinotan • Roxindole • RU-24,969 • S 14,506 • S-14,671 • S-15,535 • Sarizotan • SSR-181,507 • Sunepitron • U-92,016-A • Urapidil • Vilazodone • Xaliproden • Yohimbine Antagonists : Antipsychotics : Iloperidone • Risperidone • Sertindole ; Beta blockers : Alprenolol • Cyanopindolol • Iodocyanopindolol • Oxprenolol • Pindobind • Pindolol • Propranolol • Tertatolol ; Others : AV965 • BMY-7,378 • CSP-2503 • Dotarizine • Flopropione • GR-46611 • Isamoltane • Lecozotan • Mefway • Metitepine/Methiothepin • MPPF • NAN-190 • PRX-00023 • Robalzotan • S-15535 • SB-649,915 • SDZ 216-525 • Spiperone • Spiramide • Spiroxatrine • UH-301 • WAY-100,135 • WAY-100,635 • Xylamidine
5-HT1B
Agonists : Lysergamides : Dihydroergotamine • Ergotamine • Methysergide ; Piperazines : Eltoprazine • TFMPP ; Triptans : Avitriptan • Eletriptan • Sumatriptan • Zolmitriptan ; Tryptamines : 5-CT • 5-MT ; Others : CGS-12066A • CP-93,129 • CP-94,253 • CP-135,807 • RU-24,969 Antagonists : Lysergamides : Metergoline ; Others : AR-A000002 • Elzasonan • GR-127,935 • Isamoltane • Metitepine/Methiothepin • SB-216,641 • SB-224,289 • SB-236,057 • Yohimbine
5-HT1D
Agonists : Lysergamides : Dihydroergotamine • Methysergide ; Triptans : Almotriptan • Avitriptan • Eletriptan • Frovatriptan • Naratriptan • Rizatriptan • Sumatriptan • Zolmitriptan ; Tryptamines : 5-CT • 5-Ethyl-DMT • 5-MT • 5-(Nonyloxy)tryptamine ; Others : CP-135,807 • CP-286,601 • GR-46611 • L-694,247 • L-772,405 • PNU-109,291 • PNU-142,633 Antagonists : Lysergamides : Metergoline ; Others : Alniditan • BRL-15,572 • Elzasonan • GR-127,935 • Ketanserin • LY-310,762 • LY-367,642 • LY-456,219 • LY-456,220 • Metitepine/Methiothepin • Ritanserin • Yohimbine • Ziprasidone
5-HT1E
Agonists : Lysergamides : Methysergide ; Triptans : Eletriptan ; Tryptamines : BRL-54443 • Tryptamine Antagonists : Metitepine/Methiothepin
5-HT1F
Agonists : Triptans : Eletriptan • Naratriptan • Sumatriptan ; Tryptamines : 5-MT ; Others : BRL-54443 • Lasmiditan • LY-334,370 Antagonists : Metitepine/Methiothepin
5-HT2 receptor ligands
Agonists : Lysergamides : ALD-52 • Ergometrine • Lisuride • LA-SS-Az • LSD • LSD-Pip • Lysergic acid 2-butyl amide • Lysergic acid 3-pentyl amide • Methysergide ; Phenethylamines : 25I-NBF • 25I-NBMD • 25I-NBOH • 25I-NBOMe • 2C-B • 2C-B-FLY • 2CB-Ind • 2C-C-NBOMe • 2C-E • 2C-I • 2C-TFM-NBOMe • 2C-T-2 • 2C-T-7 • 2C-T-21 • 2CBCB-NBOMe • 2CBFly-NBOMe • Bromo-DragonFLY • DOB • DOC • DOI • DOM • MDA • MDMA • Mescaline • TCB-2 • TFMFly ; Piperazines : BZP • Quipazine • TFMPP ; Tryptamines : 5-CT • 5-MeO-α-ET • 5-MeO-α-MT • 5-MeO-DET • 5-MeO-DiPT • 5-MeO-DMT • 5-MeO-DPT • 5-MT • α-ET • α-Methyl-5-HT • α-MT • Bufotenin • DET • DiPT • DMT • DPT • Psilocin • Psilocybin ; Others : AL-34662 • AL-37350A • Dimemebfe • Medifoxamine • Oxaflozane • PNU-22394 • RH-34 Antagonists : Atypical antipsychotics : Amperozide • Aripiprazole • Carpipramine • Clocapramine • Clozapine • Gevotroline • Iloperidone • Melperone • Mosapramine • Olanzapine • Paliperidone • Pimozide • Quetiapine • Risperidone • Sertindole • Ziprasidone • Zotepine ; Typical antipsychotics : Loxapine • Pipamperone ; Antidepressants : Amitriptyline • Amoxapine • Aptazapine • Etoperidone • Mianserin • Mirtazapine • Nefazodone • Trazodone ; Others : 5-I-R91150 • AC-90179 • Adatanserin • Altanserin • AMDA • APD-215 • Blonanserin • Cinanserin • CSP-2503 • Cyproheptadine • Deramciclane • Dotarizine • Eplivanserin • Esmirtazapine • Fananserin • Flibanserin • Ketanserin • KML-010 • Lubazodone • Mepiprazole • Metitepine/Methiothepin • Nantenine • Pimavanserin • Pizotifen • Pruvanserin • Rauwolscine • Ritanserin • S-14,671 • Sarpogrelate • Setoperone • Spiperone • Spiramide • SR-46349B • Volinanserin • Xylamidine • Yohimbine
Agonists : Oxazolines : 4-Methylaminorex • Aminorex ; Phenethylamines : Chlorphentermine • Cloforex • DOB • DOC • DOI • DOM • Fenfluramine • MDA • MDMA • Norfenfluramine ; Tryptamines : 5-CT • 5-MT • α-Methyl-5-HT ; Others : BW-723C86 • Cabergoline • mCPP • Pergolide • PNU-22394 • Ro60-0175 Antagonists : Agomelatine • Asenapine • EGIS-7625 • Ketanserin • Lisuride • LY-272,015 • Metitepine/Methiothepin • PRX-08066 • Rauwolscine • Ritanserin • RS-127,445 • Sarpogrelate • SB-200,646 • SB-204,741 • SB-206,553 • SB-215,505 • SB-221,284 • SB-228,357 • SDZ SER-082 • Tegaserod • Yohimbine
Agonists : Phenethylamines : 2C-B • 2C-E • 2C-I • 2C-T-2 • 2C-T-7 • 2C-T-21 • DOB • DOC • DOI • DOM • MDA • MDMA • Mescaline ; Piperazines : Aripiprazole • mCPP • TFMPP ; Tryptamines : 5-CT • 5-MeO-α-ET • 5-MeO-α-MT • 5-MeO-DET • 5-MeO-DiPT • 5-MeO-DMT • 5-MeO-DPT • 5-MT • α-ET • α-Methyl-5-HT • α-MT • Bufotenin • DET • DiPT • DMT • DPT • Psilocin • Psilocybin ; Others : A-372,159 • AL-38022A • CP-809,101 • Dimemebfe • Lorcaserin • Medifoxamine • MK-212 • Org 12,962 • ORG-37,684 • Oxaflozane • PNU-22394 • Ro60-0175 • Ro60-0213 • Vabicaserin • WAY-629 • WAY-161,503 • YM-348 Antagonists : Atypical antipsychotics : Clozapine • Iloperidone • Melperone • Olanzapine • Paliperidone • Pimozide • Quetiapine • Risperidone • Sertindole • Ziprasidone • Zotepine ; Typical antipsychotics : Chlorpromazine • Loxapine • Pipamperone ; Antidepressants : Agomelatine • Amitriptyline • Amoxapine • Aptazapine • Etoperidone • Fluoxetine • Mianserin • Mirtazapine • Nefazodone • Nortriptyline • Trazodone ; Others : Adatanserin • Cinanserin • Cyproheptadine • Deramciclane • Dotarizine • Eltoprazine • Esmirtazapine • FR-260,010 • Ketanserin • Ketotifen • Latrepirdine • Lu AA24530 • Metitepine/Methiothepin • Methysergide • Pizotifen • Ritanserin • RS-102,221 • S-14,671 • SB-200,646 • SB-206,553 • SB-221,284 • SB-228,357 • SB-242,084 • SB-243,213 • SDZ SER-082 • Xylamidine
5-HT3 , 5-HT4 , 5-HT5 , 5-HT6 , 5-HT7 ligands
Agonists : Piperazines : BZP • Quipazine ; Tryptamines : 2-Methyl-5-HT • 5-CT ; Others : Chlorophenylbiguanide • Butanol • Ethanol • Halothane • Isoflurane • RS-56812 • SR-57,227 • SR-57,227-A • Toluene • Trichloroethane • Trichloroethanol • Trichloroethylene • YM-31636 Antagonists : Antiemetics : AS-8112 • Alosetron • Azasetron • Batanopride • Bemesetron • Cilansetron • Dazopride • Dolasetron • Granisetron • Lerisetron • Ondansetron • Palonosetron • Ramosetron • Renzapride • Tropisetron • Zacopride • Zatosetron ; Atypical antipsychotics : Clozapine • Olanzapine • Quetiapine ; Tetracyclic antidepressants : Amoxapine • Mianserin • Mirtazapine ; Others : CSP-2503 • ICS-205,930 • Lu AA21004 • Lu AA24530 • MDL-72,222 • Memantine • Nitrous Oxide • Ricasetron • Sevoflurane • Thujone • Xenon
5-HT4
Agonists : Gastroprokinetic Agents : Cinitapride • Cisapride • Dazopride • Metoclopramide • Mosapride • Prucalopride • Renzapride • Tegaserod • Velusetrag • Zacopride ; Others : 5-MT • BIMU8 • CJ-033,466 • PRX-03140 • RS-67333 • RS-67506 • SL65.0155 • Antagonists : GR-113,808 • GR-125,487 • L-Lysine • Piboserod • RS-39604 • RS-67532 • SB-203,186
5-HT5A
Agonists : Lysergamides : Ergotamine • LSD ; Tryptamines : 5-CT ; Others : Valerenic Acid Antagonists : Asenapine • Latrepirdine • Metitepine/Methiothepin • Ritanserin • SB-699,551 * Note that the 5-HT5B receptor is not functional in humans.
5-HT6
Agonists : Lysergamides : Dihydroergotamine • Ergotamine • Lisuride • LSD • Mesulergine • Metergoline • Methysergide ; Tryptamines : 2-Methyl-5-HT • 5-BT • 5-CT • 5-MT • Bufotenin • E-6801 • E-6837 • EMD-386,088 • EMDT • LY-586,713 • N -Methyl-5-HT • Tryptamine ; Others : WAY-181,187 • WAY-208,466 Antagonists : Antidepressants : Amitriptyline • Amoxapine • Clomipramine • Doxepin • Mianserin • Nortriptyline ; Atypical antipsychotics : Aripiprazole • Asenapine • Clozapine • Fluperlapine • Iloperidone • Olanzapine • Tiospirone ; Typical antipsychotics : Chlorpromazine • Loxapine ; Others : BGC20-760 • BVT-5182 • BVT-74316 • EGIS-12,233 • GW-742,457 • Ketanserin • Latrepirdine • Lu AE58054 • Metitepine/Methiothepin • MS-245 • PRX-07034 • Ritanserin • Ro04-6790 • Ro 63-0563 • SB-258,585 • SB-271,046 • SB-357,134 • SB-399,885 • SB-742,457
5-HT7
Agonists : Lysergamides : LSD ; Tryptamines : 5-CT • 5-MT • Bufotenin ; Others : 8-OH-DPAT • AS-19 • Bifeprunox • LP-12 • LP-44 • RU-24,969 • Sarizotan Antagonists : Lysergamides : 2-Bromo-LSD • Bromocriptine • Dihydroergotamine • Ergotamine • Mesulergine • Metergoline • Methysergide ; Antidepressants : Amitriptyline • Amoxapine • Clomipramine • Imipramine • Maprotiline • Mianserin ; Atypical antipsychotics : Amisulpride • Aripiprazole • Clozapine • Olanzapine • Risperidone • Sertindole • Tiospirone • Ziprasidone • Zotepine ; Typical antipsychotics : Chlorpromazine • Loxapine ; Others : Butaclamol • EGIS-12,233 • Ketanserin • LY-215,840 • Metitepine/Methiothepin • Pimozide • Ritanserin • SB-258,719 • SB-258,741 • SB-269,970 • SB-656,104 • SB-656,104-A • SB-691,673 • SLV-313 • SLV-314 • Spiperone • SSR-181,507
Releasing agents
Aminoindanes : 5-IAI • AMMI • ETAI • MDAI • MDMAI • MMAI • TAI ; Aminotetralins : 6-CAT • 8-OH-DPAT • MDAT • MDMAT ; Oxazolines : 4-Methylaminorex • Aminorex • Clominorex • Fluminorex ; Phenethylamines (also Amphetamines , Cathinones , Phentermines , etc): 2-Methyl-MDA • 4-CAB • 4-FA • 4-FMA • 4-HA • 4-MTA • 5-APDB • 5-Methyl-MDA • 6-APDB • 6-Methyl-MDA • AEMMA • Amiflamine • BDB • BOH • Brephedrone • Butylone • Chlorphentermine • Cloforex • Amfepramone • Metamfepramone • DFMDA • DMA • DMMA • EBDB • EDMA • Ethylone • Etolorex • Fenfluramine (Dexfenfluramine ) • Flephedrone • IAP • IMP • Lophophine • MBDB • MDA • MDEA • MDHMA • MDMA • MDMPEA • MDOH • MDPEA • Mephedrone • Methedrone • Methylone • MMA • MMDA • MMDMA • MMMA • NAP • Norfenfluramine • 4-TFMA • pBA • pCA • pIA • PMA • PMEA • PMMA • TAP ; Piperazines : 2C-B-BZP • 2-BZP • 3-MeOPP • BZP • DCPP • MBZP • mCPP • MDBZP • MeOPP • Mepiprazole • pCPP • pFPP • pTFMPP • TFMPP ; Tryptamines : 4-Methyl-αET • 4-Methyl-αMT • 5-CT • 5-MeO-αET • 5-MeO-αMT • 5-MT • αET • αMT • DMT • Tryptamine (itself); Others : Indeloxazine • Tramadol • Viqualine